SCHEMBL5370623

SCHEMBL5370623

COC(=O)COc1ccc(S(=O)(=O)C2([S+]([O-])Cc3ncc(C)c(OC)c3C)N=c3ccc(OC)cc3=N2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
CYP2C9 P11712 3/20 0.38
ALDH1A1 P00352 4/20 0.35
CYP2C19 P33261 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 3/20 0.34
WDR5 P61964 2/20 0.34
BRS3 P32247 2/20 0.34
KDM4E B2RXH2 2/20 0.34
DDAH1 O94760 1/20 0.34
ABCB11 O95342 1/20 0.34
ATP1A1 P05023 1/20 0.34
ATP1B1 P05026 1/20 0.34
CYP1A2 P05177 1/20 0.34
CHRM2 P08172 1/20 0.34
ABCB1 P08183 1/20 0.34
CYP3A4 P08684 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366904 0.87 CYP2C9 (0.36) CYP2C9ALDH1A1CYP2C19SMN1; SMN2KMT2A
SCHEMBL5367178 0.86 CYP2C9 (0.36) CYP2C9ALDH1A1CYP2C19SMN1; SMN2KMT2A
SCHEMBL5368037 0.82 ALDH1A1 (0.37) CYP2C9ALDH1A1LMNAKMT2AMAPT
SCHEMBL14495756 0.76 CYP2C9 (0.40) MAPK1CYP2C9ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL5368641 0.76 CYP2C9 (0.40) MAPK1CYP2C9ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL5320866 0.75 CYP2C9 (0.40) CYP2C9ALDH1A1CYP2C19SMN1; SMN2LMNA
SCHEMBL5370630 0.75 CYP2C9 (0.42) MAPK1CYP2C9ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL14495759 0.75 CYP2C9 (0.42) MAPK1CYP2C9ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL5366593 0.74 MAPK1 (0.51) MAPK1CYP2C9ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL14356226 0.71 CYP2C9 (0.40) MAPK1CYP2C9ALDH1A1CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7294716-B2 Process for preparing isomerically pure prodrugs of proton pump inhibitors ALLERGAN, INC. (US) 2007-11-13 US disclosed